About ADAPTBIO, INC.
AdaptBio is a biotechnology company pioneering the development of peptide drugs using its ADAPT platform technology, focusing on novel therapeutic modalities for high unmet medical needs, particularly in immunooncology and vaccine development.
Development of novel peptide drugs using ADAPT platform technologyEngineering of stable antibody CDR-H3 mimics as peptide therapeuticsCreation of next-gen peptide vaccines with sustained humoral and cellular immunityDrug discovery and delivery of ADAPTin therapeutic modalities with improved pharmacological propertiesCollaboration with research institutions for preclinical and clinical development
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ADAPTBIO, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.